Cargando…

T-cell differentiation and CD56+ levels in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration

Polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (AMD) are prevalent age-related diseases characterized by exudative changes in the macula. Although they share anatomical and clinical similarities, they are also distinctly characterized by their own features,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subhi, Yousif, Nielsen, Marie Krogh, Molbech, Christopher Rue, Oishi, Akio, Singh, Amardeep, Nissen, Mogens Holst, Sørensen, Torben Lykke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723695/ https://www.ncbi.nlm.nih.gov/pubmed/29165313 http://dx.doi.org/10.18632/aging.101329

Ejemplares similares

Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy
por: Sørensen, Jakob Ø., et al.
Publicado: (2020)

Chemokine Profile and the Alterations in CCR5-CCL5 Axis in Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Krogh Nielsen, Marie, et al.
Publicado: (2020)

Treatment failure in neovascular age-related macular degeneration is associated with a complex chemokine receptor profile
por: Bjerregaard, Thomas, et al.
Publicado: (2019)

Valsalva-Related Subretinal Hemorrhage as a Presenting Symptom of Polypoidal Choroidal Vasculopathy
por: Subhi, Yousif, et al.
Publicado: (2017)

Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019)

Complement factor H Y402H polymorphism results in diminishing CD4(+) T cells and increasing C-reactive protein in plasma
por: Nielsen, Marie Krogh, et al.
Publicado: (2023)

In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels
por: Subhi, Yousif, et al.
Publicado: (2013)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
por: Bhoomibunchoo, Chavakij, et al.
Publicado: (2017)

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration
por: Subhi, Yousif, et al.
Publicado: (2019)

Polypoidal Choroidal Vasculopathy in Asians
por: Wong, Chee Wai, et al.
Publicado: (2015)

Macular Hole Secondary to Polypoidal Choroidal Vasculopathy
por: Baskaran, Prabu, et al.
Publicado: (2017)

Cuticular drusen associated with aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy)
por: Fragiotta, Serena, et al.
Publicado: (2018)

Neovascular Age-Related Macular Degeneration in the Very Old (≥90 Years): Epidemiology, Adherence to Treatment, and Comparison of Efficacy
por: Subhi, Yousif, et al.
Publicado: (2017)

SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Kondo, Naoshi, et al.
Publicado: (2009)

Evaluation of the association of C5 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Liu, Ke, et al.
Publicado: (2019)

Choroidal Nevus in an Eye with Polypoidal Choroidal Vasculopathy
por: Asao, Kazunobu, et al.
Publicado: (2014)

Heart-Rate Variability Correlates to Choroidal Thickness in Central Serous Chorioretinopathy
por: Nordsten, Cecilie Bagi, et al.
Publicado: (2023)

Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration
por: Krogh Nielsen, Marie, et al.
Publicado: (2017)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015)

Polypoidal Choroidal Vasculopathy in Congolese Patients
por: Kabedi, Nelly N., et al.
Publicado: (2020)

Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Matsumiya, Wataru, et al.
Publicado: (2011)

Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy
por: Tan, Colin S., et al.
Publicado: (2021)

A Comparative Study of Choroidal Vascular and Structural Characteristics of Typical Polypoidal Choroidal Vasculopathy and Polypoidal Choroidal Neovascularization: OCTA-Based Evaluation of Intervortex Venous Anastomosis
por: Batıoğlu, Figen, et al.
Publicado: (2022)

European Prevalence of Polypoidal Choroidal Vasculopathy: A Systematic Review, Meta-Analysis, and Forecasting Study
por: van Dijk, Elon H. C., et al.
Publicado: (2022)

The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration
por: Bessho, Hiroaki, et al.
Publicado: (2012)

Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response
por: Hatz, Katja, et al.
Publicado: (2014)

Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients
por: Zhou, Huiying, et al.
Publicado: (2020)

Replacement of polyps with type 1 macular neovascularization in polypoidal choroidal vasculopathy imaged with swept source OCT angiography
por: Shen, Mengxi, et al.
Publicado: (2021)

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Jin, Ki Won, et al.
Publicado: (2021)

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Shen, Yinchen, et al.
Publicado: (2022)

Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography
por: Azar, Georges, et al.
Publicado: (2021)

SERPING1 polymorphisms in polypoidal choroidal vasculopathy
por: Li, Meng, et al.
Publicado: (2010)

Disadvantages of photodynamic therapy for polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2010)

Polypoidal Choroidal Vasculopathy: An Update on Therapeutic Approaches
por: Wong, Raymond L.M., et al.
Publicado: (2013)

Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
por: Sayman Muslubaş, Işıl, et al.
Publicado: (2016)

Polypoidal choroidal vasculopathy: Pearls in diagnosis and management
por: Anantharaman, Giridhar, et al.
Publicado: (2018)

Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
por: Singh, Sumit Randhir, et al.
Publicado: (2019)

Current management strategy of polypoidal choroidal vasculopathy
por: Ho, Christine P S, et al.
Publicado: (2018)

Microperimetry and multimodal imaging in polypoidal choroidal vasculopathy
por: Acton, Jennifer H., et al.
Publicado: (2018)

Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
por: Ijuin, Nobuo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8gum96k3g5rssitfd100fnh6mt